Denali Therapeutics Inc. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Indemnification Agreements (1)
- Sales Agreements (9)
- Amendment No. 9 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated December 7, 2022 (Filed With SEC on February 27, 2023)
- Amendment No. 8 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 8, 2022 (Filed With SEC on February 27, 2023)
- Amendment No. 7 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated March 29, 2021 (Filed With SEC on February 27, 2023)
- Amendment No. 6 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on February 26, 2021)
- Amendment No. 3 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on February 26, 2021)
- Amendment No. 5 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on February 26, 2021)
- Definitive LRRK2 Collaboration and License Agreement (Filed With SEC on November 5, 2020)
- Provisional LRRK2 Collaboration and License Agreement between the Registrant and Biogen Inc., dated August 5, 2020 (Filed With SEC on November 5, 2020)
- Amendment No. 4 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on November 8, 2018)
- Amendment No. 3 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on November 8, 2018)
- Option and Collaboration Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated January 3, 2018 (Filed With SEC on March 19, 2018)
- Amendment No. 2 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on March 19, 2018)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on November 27, 2017)
